Effectiveness between early and late temporary ileostomy closure in patients with rectal cancer: A prospective study

Curr Probl Cancer. 2017 May-Jun;41(3):231-240. doi: 10.1016/j.currproblcancer.2017.02.007. Epub 2017 Mar 2.

Abstract

A temporary stoma is often used in rectal cancer surgery to protect a distal anastomosis, which remains a major concern after rectal cancer surgery, particularly after low anterior resection. The temporary stoma is scheduled for closure. However, the optimal time of closure of the protecting stoma remains unclear because of sparse studies and data. We aimed to detect the efficacy between early and late temporary ileostomy closure in patients with rectal cancer during or after neoadjuvant chemoradiotherapy. We conducted a prospective, 2-group design between early and late ileostomy closure group in patients after rectal cancer surgery with temporary stoma. Participants were recruited in a teaching hospital in Guangzhou, China. A total of 161 patients confirmed diagnosis of rectal cancer underwent curative surgery and temporary ileostomy. Participants with temporary ileostomy received closure surgery after 1 (early) or 6 (late) months were assessed by clinical parameters and quality of life. Patients in late closure group received more adjuvant chemotherapy cycles but with comparable incidence of stoma closure-related complications and length of hospital stay compared to early closure group. Participants in late closure group with standardized postoperative chemotherapy might have a better prognosis compared with those in early closure group. An increased emphasis should be given to choose the optimal closure time of patients with rectal cancer having temporary ileostomy. Colorectal nurses could provide support to physician for observation of prognosis of different closure time.

Keywords: Chemotherapy; Complications; Ileostomy; Rectal cancer; Stoma closure; Timing.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Anastomosis, Surgical / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Chemoradiotherapy, Adjuvant / methods
  • Female
  • Humans
  • Ileostomy / adverse effects*
  • Ileostomy / methods
  • Laparoscopy / adverse effects*
  • Laparoscopy / methods
  • Length of Stay
  • Male
  • Middle Aged
  • Neoadjuvant Therapy / methods
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Quality of Life*
  • Rectal Neoplasms / nursing
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / therapy*
  • Rectum / surgery*
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents